Skip Navigation

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrowRequest Permissions
Google Scholar
Right arrow Articles by Tennekes, H.
Right arrow Articles by Kunz, H.W.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Tennekes, H.
Right arrow Articles by Kunz, H.W.
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

© 1985 Oxford University Press

other

Quantitative aspects of enhanced liver tumour formation in CF-1 mice by dieldrin

Henk Tennekes 1, Ben van Ravenzwaay and H.Werner Kunz

The German Cancer Research Centre, Institute of Biochemistry Im Neuenheimer Feld 280, D-6900 Heidelberg, FRG

The dose-response characteristics of dieldrin-mediated enhancement of liver tumour formation in CF-1 mice were analysed, using existing tumour data from chronic feeding studies at six levels of continuous exposure, involving a total of > 1500 animals. The dose-response relationship can be expressed as: Dx x Tx = D0 x T0 = constant, where T0 = the median liver tumour induction period in control CF-1 mice, Tx = the median liver tumour induction period in dieldrin-treated mice at a dose level Dx, D0 = the background dose equivalent for the induction of ‘spontaneous’ liver tumours, Dx = the sum of background dose (D0) and actual dieldrin dose ({delta}x). The relationship, which is a Druckrey equation (D x Tn = constant) where n = 1, indicates that: (i) the velocity of liver tumour development is proportional to the daily dose level (Dx), (ii) the total tumourigenic dose is constant across all doses, (iii) the effects of dieldrin on the neo-plastic process in mouse liver are essentially irreversible and cumulative, and (iv) there is no evidence for a threshold level. However, when {delta}x «D0, the actual contribution of dieldrin to tumour formation is expected to be negligible.


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?




Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.